Related Experiment Video
Updated: Jun 2, 2026

11:54
Transcranial Direct Current Stimulation (tDCS) in Mice
Published on: September 23, 2018
Flash visual evoked potentials in mice can be modulated by transcranial direct current stimulation
M Cambiaghi1, L Teneud, S Velikova
1San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Institute of Experimental Neurology (INSPE), Experimental Neurophysiology Unit, Milan, Italy.
Neuroscience
|April 26, 2011
Summary
Transcranial direct current stimulation (tDCS) can alter visual evoked potentials (VEPs) in mice, similar to humans. Anodal tDCS increased VEP amplitude, while cathodal stimulation decreased it, supporting tDCS research in animal models.
Area of Science:
- Neuroscience
- Ophthalmology
- Medical Devices
Background:
- Visual evoked potentials (VEPs) are crucial for studying visual system function and disorders in mice.
- Transcranial direct current stimulation (tDCS) is known to modulate VEPs in humans.
- The efficacy of tDCS in modulating VEPs in mice remains largely unexplored.
Purpose of the Study:
- To investigate whether tDCS can modulate VEPs in mice in a polarity-dependent manner, mirroring human responses.
- To establish a foundation for using mouse models to explore tDCS mechanisms and therapeutic potential.
Main Methods:
- Flash-VEPs were recorded in C57BL/6 mice under sevoflurane anesthesia.
- Mice received 10 minutes of either anodal tDCS, cathodal tDCS, or no stimulation.
- VEP P1 peak amplitudes were analyzed before, and at 0, 5, and 10 minutes after stimulation.
Main Results:
- Anodal tDCS significantly increased P1 amplitude by over 25% compared to no stimulation.
- Cathodal tDCS decreased P1 amplitude by approximately 30%.
- These tDCS effects showed a tendency to return to baseline within 10 minutes post-stimulation.
Conclusions:
- tDCS demonstrates polarity-dependent modulation of VEPs in mice, consistent with findings in humans.
- These results validate the use of mouse models for investigating tDCS mechanisms.
- This research supports the potential of tDCS for therapeutic applications in neurological and visual disorder models.

